DiGeorge Syndrome: A not so rare disease

Clinics

Volumn 65, Issue 9, 2010, Pages 865-869

  Fomin, Angela B F ^a   Pastorino, Antonio Carlos ^a   Kim, Chong Ae ^a   Pereira, Alexandre C ^a   Carneiro Sampaio, Magda ^a   Abe Jacob, Cristina Miuki ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

22q11.2 deletion; DiGeorge syndrome; Immunologic deficiency syndromes; Thymus

Indexed keywords

EID: 78249289994     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322010000900009     Document Type: Article

References (24)

1. Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2.2 deletion syndrome. Lancet. 2007; 370:1443-52, doi: 10.1016/S0140-6736(07)61601-8.
2. Araujo AC, Fortuna ES, Carneiro-Sampaio MMS, Grumach AS. Primary Immunodeficiency diseases: a presentation of 6 cases. Braz J med Biol Res. 1988; 21:915-7.
3. Kokitsu-Nakata MN, Guion-Almeida ML, Richieri-Costa A. 22q11 deletion Syndrome and limb anomalies: report on two Brazilian patients. Cleft palate- Craniofacial J. 2008; 45:561-6, doi: 10.1597/06-170.1.
4. Piliero LM, Sanford AN, McDonald-McGinn DM, Zackai EH, Sullivan KE. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood. 2004; 103:1020-25, doi: 10.1182/blood-2003-08-2824.
5. Jiang L, Hou Z, Duan C, Chen B, Chen Z, Li Y, Huan Y, et al. Isolated congenital heart disease is associated with the 22q11.2 deletion even though it is rare. Int J Cardiol. 2009 Nov 16. [Epub ahead of print] PubMed PMID: 19923022.
6. Routes JM, Grossman WJ, Versky J, Laessing RH, Hoffman GL, Brokopp CD. Statewide Newborn Screening for Severe T-Cell Lymphopenia. JAMA 2009; 302:2465-70, doi: 10.1001/jama.2009.1806.
7. Notarangelo L, Casanova JL, Conley ME, Chapel H, Fischer A, Puck J, et al. Primary immunodeficiency diseases: An update from the International Union of Immunological Societ ies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol. 2006; 117:883-96, doi: 10.1016/ j.jaci.2005.12.1347.
8. Comans-Bitter WM, De Groot R, Van den Beemd R, Neijens HJ, Hop WCJ, Groenveld K, et al. Immunophenotyping of blood lymphocytes in childhood. References values for lymphocytes subpopulations. J Pediatr. 1997; 130:388-93.
9. Thomas JA, Graham JM Jr. Chromosome 22q11 deletion syndrome: an update and review for the primary pediatrician. Clin Pediatr (Phila). 1997; 36:253-66, doi: 10.1177/000992289703600502.
10. Matsuoka R, Kimura M, Scambler PJ, Morrow BE, Imamura S, Minoshima S, et al. Molecular and clinical study of 183 patients with conotruncal anomaly face syndrome. Hum Genet. 1998; 103:70-80, doi: 10. 1007/s004390050786.
11. Gioli-Pereira L, Pereira AC, Mesquita SM, Lopes AA, Krieger JE. PCR screening for 22q11.2.2 microdeletion: development of a new costeffective diagnostic tool. Clin Chim Acta. 2006; 369:78-81, doi: 10.1016/j. cca.2006.01.005.
12. Shprintzen RJ, Higgins AM, Anstshel K, Fremont W, Roizen N, Kates W. Velo-cardio-facial syndrome. Cur Opin Pediatr. 2005; 17:725-30, doi: 10. 1097/01.mop.0000184465.73833.0b.
13. Goodship J, Cross L, Liling J, Wren C. A population study of chromosome 21q11 deletions in infancy. Arch Dis Child. 1998; 79:348-51, doi: 10.1136/adc.79.4.348.
14. Shprintzen RJ. Velo-cardio-facial syndrome: 30 years of study. Dev Disabil Res Rev. 2008; 14:3-10, doi: 10.1002/ddrr.2.
15. Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, et al. Role of TBX1 in human del 22q11.2 syndrome. Lancet. 2003; 362:1366-73, doi: 10.1016/S0140-6736(03)14632-6.
16. Jalali GR, Vorstman JAS, Errami AB, Vijzelaar R, Biegel J, Shaikh T, et al. Detailed analysis of 22q11.2 with a high density MLPA probe set. Human Mutation. 2008; 29:433-40, doi: 10.1002/humu.20640.
17. Fernandez L, Nevado J, Santos F, Heine-Suñer D, Martinez-Glez V, Garcia-Miñaur S, et al. A deletion and a duplication in distal 22q11.2 deletion syndrome region. Clinical implications and review. BMC Medical Genetics. 2009; 10:48, doi: 10.1186/1471-2350-10-48.
18. Oskarsdottir S, Vujic M, Fasth A. Incidence and prevalence for the 22q11.2 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child. 2004; 89:148-51, doi: 10.1136/adc.2003.026880.
19. Goldmuntz E, Clark BJ, Mitchell LE, Jawad AF, Cuneo BF, Reed L, et al. Frequency of 22q11.2 deletions in patients with conotruncal defects. J Am Coll Cardiol. 1998; 32:492-8, doi: 10.1016/S0735-1097(98)00259-9.
20. Sullivan KE. The clinical, immunological and molecular spectrum of chromosome 22q11.2.2 deletion syndrome and DiGeorge syndrome. Curr Opin Allergy Clin Immunol. 2004; 4:505-12, doi: 10.1097/00130832-200412000-00006.
21. Sullivan KE, McDonald-McGinn DM, Driscoll D, Emanuel BS, Zackai EH, Jawad AF. Longitudinal analysis of Lymphocyte function and numbers in the first year of life and chromosome 22q11.2.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Labor Diag Immunol. 1999; 6:906-11.
22. Chinen J, Rosenblatt HM, Smith EO, Shearer WT, Noroski LM. Longterm assessment of T-cell population in DiGeorge syndrome. J Allergy Clin Immunol. 2003; 111:573-9, doi: 10.1067/mai.2003.165.
23. Butts SC. The facial phenotype of the velo-cardio-facial syndrome. Int J Pediatr Otorhinolaryngol. 2008; 73:343-50, doi: 10.1016/j.ijporl.2008.10.011.
24. Gothelf D, Michaelovsky E, Frish A, Burg M, Carmel M, Steinberg T, et al. Association of the low activity COMT 158 Met allelete with ADHD and OCD in subjects with velocardiofacial syndrome. Int Neuropsychopharmaco. 2007; 10:301-8, doi: 10.1017/S1461145706006699.